4.7 Article

Lemon Balm and Corn Silk Mixture Alleviates Metabolic Disorders Caused by a High-Fat Diet

Journal

ANTIOXIDANTS
Volume 11, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/antiox11040730

Keywords

corn silk (stigma of Zea mays L. fruit); high-fat diet (HFD); lemon balm (Melissa officinalis L.); 1:1 (w:w) mixture of lemon balm and corn silk extracts (M-LB/CS); metabolic disorders

Ask authors/readers for more resources

This study investigated the dose-dependent effect of a mixture of lemon balm and corn silk extracts on high-fat diet-induced metabolic disorders. The results showed that the mixture significantly inhibited body weight gain, adipocyte hypertrophy, and abnormal lipid accumulation in the blood. It also prevented pancreatic and liver injury, and protected the kidney. The prophylactic effect of the mixture was comparable to that of metformin.
We recently reported that varying combination ratios of lemon balm (Melissa officinalis L.) and corn silk extracts (Stigma of Zea mays L. fruit) could reduce the obesity caused by a high-fat diet (HFD). The present study investigated the dose-dependent effect of a 1:1 (w:w) mixture of lemon balm and corn silk extracts (M-LB/CS) on HFD-mediated metabolic disorders and compared the effect with metformin. Oral administration of 50-200 mg/kg of M-LB/CS for 84 days significantly inhibited HFD-induced body weight gain, adipocyte hypertrophy, and lipogenic gene induction without affecting food consumption in mice. Biochemical analyses showed that M-LB/CS blocked abnormal lipid accumulation in the blood by escalating fecal lipid excretion. In addition, M-LB/CS prevented HFD-mediated pancreatic atrophy, decreased the number of insulin- and glucagon-immunoreactive cells, and inhibited increases in glycated hemoglobin, glucose, and insulin. Moreover, M-LB/CS also reduced hepatic injury, lipid accumulation, gluconeogenesis, and lipid peroxidation in parallel with the induction of AMP-activated protein kinase and antioxidant enzymes. Furthermore, M-LB/CS protected the kidney by inhibiting tubular vacuolation and reducing serum creatinine and blood urea nitrogen levels. The prophylactic effect of 100 mg/kg M-LB/CS-administration was comparable to that of metformin. Therefore, M-LB/CS may be an alternative option for managing obesity and its related metabolic disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available